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Abstract: 
Congenital Marfan syndrome is a rare and 
severe disease of the newborn, causing 
devastating and often fatal effects on the 
cardiovascular, pulmonary, and musculoskeletal 
systems. Familial mutations of FBN1 have been 
studied and identified in Marfan syndrome, but 
the congenital variant is often due to de novo 
mutations, limiting the diagnostic capabilities of 
genetic screening. Ultrasound is essential for 
early diagnosis and management, yet few cases 
of sonographic diagnosis have been cited in the 
literature. This report outlines one such case of 
congenital Marfan syndrome diagnosed at 24-
week ultrasound. Further detailed reports should 
aim to improve screening, diagnosis, and 
treatment of congenital Marfan syndrome to 
advance options in family planning and disease 
management. 
1University of Iowa, Iowa City, IA 
2 Mercy Hospital, Des Moines, IA 
 
Introduction 
 
Marfan syndrome (MFS) is a disease of 
the connective tissue caused by a 
mutation of the FBN1 gene, and 
involves the integument, cardiac, ocular, 
and the pulmonary systems.  Among the 
most common presenting symptoms are 
bilateral ectopia lentis, myopia, bone 
overgrowth, disproportionately long 
limbs (dolichostenomelia), scoliosis, 
spontaneous pneumothorax, and 
numerous heart defects.  The greatest 
contributors to disease morbidity and 
mortality are cardiac anomalies 
including aortic root dilation, aortic 
dissection, and valvular prolapse.   
 
Diagnosis of MFS is largely dependent 
on clinical identification of a spectrum of 
phenotypic presentations.  Most MFS 
cases are not diagnosed until 
adolescence due to the late 
presentation of the characteristic 
features and lack of earlier screening 
tools. Diagnostic tools include the Gent 
revised criterion and molecular genetic 
testing for FBN1 mutation to verify.  One 
exception allowing for earlier diagnosis 
of MFS is amniocentesis and CVS for 
screening of familial MFS.  However, 
this screening is only available in cases 
with a pre-identified disease-causing 
allele. Even with an allele isolated, the 
testing gives no indication of disease 
spectrum and severity, as MFS has 
significant clinical heterogeneity and 
variability.   Additionally, the most 
severe form of the disease is the 
neonatal variant, which is most 
commonly caused by a spontaneous de 
novo mutation.   
 
Congenital MFS is an extremely rare 
and more severe disease variant.  
Physical presentation includes 
elongated stature, flexion contractures, 
characteristic facial dysmorphology, and 
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severe progressive cardiac disease.   
Neonates often face intractable 
congestive heart failure and die within 
the first 2 years of life. Early 
identification is essential in 
management, yet difficult as most are a 
result of spontaneous de novo 
mutations. The diversity of de novo 
mutations is beyond prenatal genetic 
testing at this point, placing extra weight 
on the diagnostic capability of 
ultrasound in unsuspecting parents. 
Early sonographic diagnosis of this 
lethal condition is essential for perinatal 
management and family counseling.  
Perinatal management requires a 
pediatric cardiologist, NICU availability, 
and palliative care representation.  
Benefits of early diagnosis to the family 
include provision of genetic counseling, 
preventative management of carriers, 
and reassurance of unaffected relatives. 
As diagnostics improve and more 
outcomes are documented, ultrasound 
may guide choices regarding 
termination. Additionally, new treatment 
options may be available as the disease 
pathogenesis is better understood. 
Currently TGF-beta has a major role 
and in mice models, losartan has been 
proven effective in the primary 
prevention of progressive aortic root 
dilation.   
 
 
 
Figure 1:  24w4d Ultrasound 
 
A: Left Ventricular Outflow Tract: no abnormalities of valvular roots noted at 24w4d, but appeared on 
following ultrasound at 28w4d. B: RV Outflow Tract. C: Arachnodactyly D: Right Femoral Length >95% E: 
Right Radial Length >95% F: Right Ulnar Length >95%. G/H: Fist clenching with thumb extending laterally 
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Case Report: 
 
Prenatal Course 
 
A 19-year-old G1P0 female presented 
for an initial OB visit at 22 4/7 weeks 
based on LMP. Initial ultrasound dated 
gestational age at 24w0d, with a 2
week discrepancy between long bone 
and abdominal circumference 
measurements, with femur and humerus 
lengths above 95th percentile. Patient 
was then seen in High Risk Clinic with 
an ultrasound dating the pregnancy at 
24w4d with the following abnormal 
findings: long bone measurements 
above 95%, clenched fists, 
arachnodactyly, and subjectively high
normal amniotic fluid volume. 
 
Follow-up ultrasound dated 28w4d 
demonstrated post valvular dilation of 
the left and right ventricular outflow 
tracts, as well as persistence of previous 
findings of fetal long bones and feet 
length greater than the 95th percentile, 
thumb extending beyond lateral border 
of hand when clenched in a fist. The 
fetal heart evaluation raised further 
concerns for possible congenital Marfan 
syndrome. 
 
Ultrasound at 37w5d showed AFI of 
6.79; assessment for fetal anomalies 
was not done at this time. Fetal 
evaluation prior to delivery at 38w5d 
identified oligohydramnios (AFI
persistence of elongated long bones, 
and a reassuring biophysical profile with 
a BPP 8/8.  Fetal echo revealed dil
of the aortic root, proximal pulmonary 
artery, and pulmonary valve annulus. 
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Figure 2: Dilated aortic root evident at 28w4d
 
Delivery 
 
Patient was induced due to severe 
oligohydramnios at 38.5 weeks with 
support of the NICU and pediatric 
cardiology. Baby was a 3.01 kg (11
25%) female with Apgar scores of 8 and 
9 at one and five minutes. Head 
circumference measured 32.5 cm (4
10%), and length measured 53 cm (76
90%).  During labor, the fetus has 
persistent tachycardia (initial HR 190). 
Postnatal physical exam was significant 
for micrognathia, pectus excavatum, 
respiratory difficulty, and many 
additional findings consistent with MFS
including flexion contractures of all limb 
joints, wasting of leg muscles, 
arachnodactyly, and elongated 
extremities. Grade IV/VI systolic murmur 
was heard throughout with palpable 
thrill. Echocardiogram revealed aortic 
root dilation and mild insufficiency. Both 
sinuses of Valsalva and the supra
ridge measurements plot above the 95% 
for BSA on the Roman Gra
Additionally noted on echo was 
dysplastic mitral and tricuspid valves 
with moderate insufficiency, pulmonary 
valve insufficiency, and dilation of both 
atria and the left ventricle.  A moderate 
sized PFO was noted with a left to right 
shunt, as well as small VSD with 
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restrictive left to right shunt.  Infant was 
hypertensive with systolic blood 
pressures in the 90’s-110’s. MRA of 
neck showed abnormally elongated and 
tortuous carotid arteries, consistent with 
underlying collagen disease. Osseous 
survey revealed S-shaped 
thoracolumbar scoliosis. Ophthalmologic 
exam showed mid-peripheral iris with 
prominent transillumination defects and 
no ectopia lentis. Diaphragmatic 
paralysis was evident on ultrasound and 
fluoroscopy. Bronchoscopy revealed 
laryngomalacia and 
tracheobronchomalacia.  
 
Immediately after birth, the infant 
experienced respiratory distress which 
required intubation and positive airway 
pressures. Despite continuing full NICU 
support, the baby had worsening 
respiratory distress, poor systemic 
perfusion, and a severe mixed acidosis. 
Pneumothorax was identified and 
showed no improvement with three 
thoracocentesis. At 35 days of life, 
parents requested withdrawal of support 
and the patient died shortly after.  
 
Genetic Analysis 
 
A three-generation pedigree was 
obtained. There is no known family 
history of Marfan syndrome or sudden 
death. Chromosome analysis and 
chromosomal microarray were both 
normal.  FBN1 gene sequencing found a 
heterozygous IVS25TA transversion. 
This change has not been previously 
reported as either a mutation or a 
polymorphism. Findings were consistent 
with a disease-causing mutation. 
 
 
Literature Review and Discussion 
 
Based on our survey of the literature in 
PUBMED (1950 to present), this is only 
the seventh case of congenital Marfan 
syndrome detected prenatally and 
confirmed on post-natal evaluation. 
Most recently was in 2007, with 
elongated femur noted at 22 weeks and 
cardiomegaly at 32 weeks.  The other 
four cases were diagnosed in utero with 
findings of cardiomegaly, atrioventricular 
valve insufficiency and dilatation of the 
outflow tracts. These were detected at 
29, 33, 34 and 37 weeks.  Of these five 
previous cases, one pregnancy was 
terminated, one fetus died in utero and 
three died as neonates (Table 1).  
Retrospective reviews state the earliest 
possible sonographic findings to raise 
suspicion for MFS are femur length 
>95% at 22 weeks.6  No previous 
studies have elaborated on the 
presence of abnormal feet and hand 
posturing en utero, nor utilized 4d 
sonographic capabilities to capture the 
images as we have noted in this unique 
case. 
 
The case is important in that extremely 
long bones were detected as early as 24 
weeks of gestation, along with 
dysmorphological features involving 
fetal hands and feet. The early 
diagnosis allowed the obstetrical team 
to educate the patient on potential 
outcomes, and prepare for delivery in an 
intensive care setting with a cardiology 
team. The evidence in this case was not 
sufficient to offer pregnancy termination, 
but this option may be considered in the 
future with the advent of improved 
diagnostic techniques and more 
documented neonatal outcomes.   
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Table 1: Previous Sonographic Diagnosis of Congenital Marfan Disease 
Date of case GA of initial 
ultrasound 
findings 
Description of ultrasound 
findings 
Physical findings at 
birth 
Outcome Genetics 
2007 (7) 22 Bilateral choroid plexus 
cysts, mild tricuspid 
regurgitation, and femur 
length above 95% 
Typical marfanoid 
habitus with cutis 
laxa, arachnodactyly 
and flexion 
contractures. 
Death at 9
th
 post-
natal day due to 
worsening 
congestive heart 
failure. 
* 
1995 (8) 34  Echo: typical cardiac 
manifestations 
* Died at 2 months of 
age due to 
congestive heart 
failure. 
* 
2006 (9) 33 weeks Cardiomegaly, dilated 
ascending aorta and 
pulmonary artery, 
pulmonary atresia, 
dysplastic mitral and 
tricuspid valves,  
Post-mortem: 
arachnodactyly, 
arthrogryposis, 
senile looking face, 
hypoplastic lungs, 
massive heart (50g, > 
double the 95 
percentile) 
Fetus died suddenly 
at 39 weeks 
gestation 
Mutation in the 
exon 26 of FBN1 
1994 (10) 37 Cardiomegaly, 
atrioventricular valve 
insufficiency and 
dilatation of the outflow 
tract 
* * * 
1999, (11) 29  Cardiomegaly dilated 
right atrium/right 
ventricle, dysplastic 
tricuspid valve, and 
severe tricuspid 
regurgitation.  
Slender fingers and 
toes, body length at 
90%, weight <10%, 
aged appearance, 
non-paralytic 
hypotonia 
 
Died at age of 3 
months due to 
heart failure, 
cardiomegaly, and 
lobar emphysema. 
Substitution of 
G by A at codon 
1032 in exon 25 
in long arm of 
chromosome 
15. De novo 
mutation 
suggestion by 
absence of 
affected family 
members. 
1981 (12) 24 weeks Significantly lengthened 
limbs in a mother with a 
previously affected child.  
* * * 
*No information available. 
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In summary, congenital Marfan 
syndrome cannot be diagnosed at this 
time with invasive genetic testing. 
Careful sonographic assessment and 
heightened index of suspicion for 
abnormal limb measurements are 
critical in diagnosing this in utero. 3D 
ultrasound allows for clear visualization 
of the long bone and cardiac features to 
aid in patient education and clinical 
management. 
 
I would like to extend a special thank 
you to the staff at the Perinatal Center, 
and Dr. Hwang for his mentorship. 
Additionally I would like to acknowledge 
Dr. Niebyl for her guidance in writing 
and editing the paper for publication.  
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